Bactericidal activity of daptomycin against vancomycin-resistantEnterococcus faecium in an in vitro pharmacokinetic model (Q54284517)

27 May 2018

reason for preferred rank

title

Bactericidal activity of daptomycin against vancomycin-resistantEnterococcus faecium in an in vitro pharmacokinetic model (English)

1 reference

24 October 2022

Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

Enterococcus faecium

1 reference

1 reference

E. Bingen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

C. Doit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

N. Lambert-Zechovsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

M. Tod

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

O. Petitjean

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

F. Bourgeois

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

P. Mariani-Kurkdjian

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666362

24 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1666362

24 October 2022

publication date

1 December 1991

1 reference

27 May 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01984930.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01984930/fulltext.html

24 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01984930

24 October 2022

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

24 October 2022

published in

1 reference

27 May 2018

volume

10

1 reference

27 May 2018

issue

12

1 reference

27 May 2018

page(s)

1062-1065

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01984930

exact match

0 references

cites work

The enterococcus: "putting the bug in our ears".

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Daptomycin (LY146032) treatment of experimental enterococcal endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984930

Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.

21 January 2018

1 reference

12 December 2020

Antibiotic resistance in enterococci

1 reference

12 December 2020

Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.

1 reference

12 December 2020

Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.

1 reference

12 December 2020

Suboptimal effect of daptomycin in the treatment of bacteremias

1 reference

12 December 2020

In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci

1 reference

12 December 2020

High-level vancomycin-resistant enterococci causing hospital infections

1 reference

12 December 2020

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01984930

1 reference

27 May 2018

1 reference

27 May 2018